AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Efficacy of Electroacupuncture for Acute Herpes Zoster-Associated Pain and Biomarker Evaluation

RecruitingNAAges 20 Years - 80 YearsAllDexiong Han
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Background: Herpes zoster (HZ) is an acute dermatological condition caused by the varicella-zoster virus. Its onset is characterized by severe pain, imposing significant physical and psychological burdens on patients. Acupuncture offers distinct advantages in treating acute herpes zoster and associated pain. However, the therapeutic efficacy of electroacupuncture for acute herpes zoster, its potential to reduce PHN incidence, and the role of biomarkers in predicting PHN incidence require further clinical validation. Methods: A total of 228 patients with acute herpes zoster will be recruited from 3 hospitals and randomly assigned to EA group or medication-alone group or sham acupuncture group in a 1:1:1 ratio, utilizing multicenter stratified block randomization. The trial will involve a 2 week treatment period, and a 3-month follow-up period. All variables will be evaluated at week 0, w

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Patients who meet the diagnostic criteria for acute HZ27 and skin symptom appears less than 7 days; 2. Only have lesions in the trunk and limbs; 2\. Patients with a Numerical Rating Scale (NRS) score โ‰ฅ 4; 3. Aged between 20 and 80 years; 4. Patients voluntarily participate in the trial and are willing to sign the informed consent. Exclusion Criteria: 1. Special types of HZ that occur in head, eyes, viscera, etc. or those combined with other skin diseases; 2. Has received relevant treatment and it may affect the observation indicators; 3. Pregnant and lactating women; 4. Patients who are allergic to iodophor or other topical disinfectants, or a history of sudden, potentially life-threatening systemic allergic reactions; 5. Those who are afraid of acupuncture or have metal implants and are not suitable for EA treatment; 6. Those with contraindications to pregabalin such as congestive heart disease and heart failure; 7. Patients with severe primary diseases such as liver, kidney, cardiovascular and cerebrovascular, metabolic, autoimmune system diseases, malignant tumors, etc., and those with mental illness; 8. Patients who have hematologic diseases or coagulation disorders; 9. Patients who are currently participating in other clinical studies.
๐Ÿ’Š

What it tests

  • Acupuncture
  • Sham
  • Valacyclovir, pregabalin and mecobalamin
๐Ÿ“

Where

1 site
the Third Affiliated Hospital of Zhejiang Chinese Medical University
Hangzhou, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy